This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The state-run mental hospital must improve patient safety at its satellite campus or it will lose eligibility for Medicare funding, inspectors warn.
Pharmaceutical industry and patients representatives want to stop restricting Medicare funding for a controversial Alzheimer’s drug. Critics say it should never have been approved.
A federal program penalizes hospitals for having the high numbers of patient infections and potentially avoidable complications, but many of them it simultaneously rates as among the best in the country.
The loss of a key Democrat likely means dental care for seniors won't be included in Medicare coverage.
Federal officials say complaints are rising from seniors tricked into buying policies, either without their consent or lured by questionable information.
Provisions in Democrats' Medicare prescription drug pricing crack open the door to reforms that could have dramatic effects, experts say.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The Lund Report asked the Congressman about what makes his plan different from the proposal he recently voted against.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
A look at the policies on the table and what they will and won’t do to rein-in the cost of pharmaceuticals.
A poll found the vast majority of adults support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.
In the 56 years since Medicare was established, few benefits have been added. That may change if Congress passes Democrats’ budget bill.
